Showing results (141-150 of 324) with videos related to

Sort By:
Pageof 33
Genes, Chromosomes & Cancer|September 23, 2015
Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndromeTheodora Malli, Veronika Buxhofer-Ausch, Melanie Rammer, et al.
Haematologica|February 9, 2019
Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experienceRon Ram, Christof Scheid, Odelia Amit, et al.
Cancers|August 23, 2020
The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior PrognosisNormann Steiner, Karin Jöhrer, Selina Plewan, et al.
Plos One|June 14, 2013
The role of the e3 ligase cbl-B in murine dendritic cellsStephanie Wallner, Christina Lutz-Nicoladoni, Christoph H Tripp, et al.
Annals of Hematology|December 3, 2016
Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AMLUdo Holtick, Marco Herling, Natali Pflug, et al.
Journal for Immunotherapy of Cancer|November 7, 2022
Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospectsMaximilian Boesch, Lena Horvath, Florent Baty, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 11, 2020
Phosphorylated PEG-emulsifier: Powerful tool for development of zeta potential changing self-emulsifying drug delivery systems (SEDDS)Julian Dominik Wolf, Markus Kurpiers, Roman Xaver Götz, et al.
Oncoscience|May 27, 2016
High prevalence of side population in human cancer cell linesMaximilian Boesch, Alain G Zeimet, Heidi Fiegl, et al.
Journal of Clinical Apheresis|March 7, 2020
Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma-A case reportPhilipp Gauckler, Johannes Leierer, Florian Kocher, et al.
Translational Lung Cancer Research|February 11, 2021
High indoleamine-2,3-dioxygenase 1 (IDO) activity is linked to primary resistance to immunotherapy in non-small cell lung cancer (NSCLC)Florian Kocher, Arno Amann, Kai Zimmer, et al.
Pageof 33